Home › Funds › ALLEN HOLDING INC /NY › IBRX
ALLEN HOLDING INC /NY position in IBRX
IMMUNITYBIO INC · Health Care
ALLEN HOLDING INC /NY reported holding 687,571 shares of IBRX (IMMUNITYBIO INC) in its Q3 2026 13F filing — a position valued at US$6.5M, representing 0.56% of its reported portfolio and ranking #9 among its reported holdings. ALLEN HOLDING INC /NY has disclosed IBRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How ALLEN HOLDING INC /NY's IBRX position evolved
ALLEN HOLDING INC /NY first disclosed a stake in IBRX in Q3 2023 at 687,571 shares (US$1.2M). The position peaked in Q3 2026 at 687,571 shares, worth US$6.5M. Across 13 filings, ALLEN HOLDING INC /NY held the position steady without any share-count change. The most recent filing (Q3 2026) shows 687,571 shares valued at US$6.5M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 687.57K | $1.16M | New |
| Q4 2023 | 687.57K | $3.45M | Hold |
| Q1 2024 | 687.57K | $3.69M | Hold |
| Q2 2024 | 687.57K | $4.35M | Hold |
| Q3 2024 | 687.57K | $2.56M | Hold |
| Q4 2024 | 687.57K | $1.76M | Hold |
| Q1 2025 | 687.57K | $2.07M | Hold |
| Q2 2025 | 687.57K | $1.82M | Hold |
| Q3 2025 | 687.57K | $1.69M | Hold |
| Q4 2025 | 687.57K | $1.36M | Hold |
| Q1 2026 | 687.57K | $5.27M | Hold |
| Q2 2026 | 687.57K | $6.02M | Hold |
| Q3 2026 | 687.57K | $6.49M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IBRX and 13F data
IBRX (IMMUNITYBIO INC) is a Health Care company. 66 other funds we track also report a position in IBRX — the largest reported positions include GREAT POINT PARTNERS LLC (US$26.3M), Sound Capital Solutions LLC (US$9.8M), Clearwater Capital Advisors, LLC (US$6.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IBRX
- GREAT POINT PARTNERS LLC 3.00M sh · $26.27M · Q2 2026
- Sound Capital Solutions LLC 1.12M sh · $9.81M · Q2 2026
- Clearwater Capital Advisors, LLC 717.52K sh · $6.77M · Q3 2026
- Kercheville Advisors, LLC 613.38K sh · $5.79M · Q3 2026
- SHEETS SMITH WEALTH MANAGEMENT 512.57K sh · $4.84M · Q3 2026
- Legacy Capital Group California, Inc. 446.00K sh · $4.21M · Q3 2026
More on ALLEN HOLDING INC /NY
FAQ
How long has ALLEN HOLDING INC /NY held IBRX?
ALLEN HOLDING INC /NY has disclosed IBRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is ALLEN HOLDING INC /NY's current position in IBRX?
As of Q3 2026, ALLEN HOLDING INC /NY holds 687.57K shares of IBRX (IMMUNITYBIO INC), valued at $6.49M, representing 0.56% of its reported portfolio and ranking #9.
Has ALLEN HOLDING INC /NY been buying or selling IBRX?
In the latest 13F filing (Q3 2026), ALLEN HOLDING INC /NY held unchanged its position in IBRX. The position peaked in Q3 2026 at 687.57K shares.
Which other funds hold IBRX?
Other major institutional holders of IBRX include GREAT POINT PARTNERS LLC, Sound Capital Solutions LLC, Clearwater Capital Advisors, LLC, among 66 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.